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Bone is one of the “organs” with the most spontaneous regenerative 
capabilities in the human body. Principally, a dynamic connective 
tissue formed as a direct result of the self assembly and mineralization 
of the extracellular matrix produced primarily by bone-forming cells or 
osteoblasts, in a remarkable orchestra-like interaction with two other 
cell types (at least to-date); osteocytes and osteoclasts maintaining and 
resorbing bone, respectively. 
Yet, it continues to be the second most transplanted tissue after blood 
with millions of bone grafts performed annually. Indeed, an osseous defect 
can cause serious functional abnormalities and aesthetic deformities - 
thereby impacting overall quality of life. Such defects may result from 
congenital abnormalities, ablative surgery or traumatic avulsion, to name 
a few (Figure 1A). Luckily, small bone defects tend to heal efficiently 
via the afore-mentioned physiological regenerative processes. On the 
other hand, healing of bone fractures and reconstruction of critical-sized 
bone defects continue to present a significant challenge for orthopedists, 
traumatologists and maxillofacial surgeons, alike, as well as their patients 
and care-givers. Indeed, for osteoregeneration to yield proper -fracture- 
healing, mechanical stability in the defect site, osteogenic cells, and 
osteoinductive growth factors in combination with a suitable carrier or 
delivery system, conceptualized a decade ago (in 2007) as the “Diamond 
Concept” are necessary (Figure 1B).1 
Yet, the long-standing autologous bone grafts continue to be routinely 
employed despite the well-documented deficiencies such as limited graft 
accessibility, donor site morbidity and increased costs. As a fine alternative, 
distraction osteogenesis; a prevailing surgical technique widely used for 
bone lengthening, is becoming increasingly popular in clinical craniofacial 
orthopedics and oro-maxillofacial (and mid-face) orthognathics since the 
documentation of the first clinical mandibular distraction osteogenesis 
back in the 1990s.2 
Briefly, distraction osteogenesis biologically resembles fracture healing 
and includes performing an osteotomy followed by gradually distracting 
(pulling away) the two bone segments resulting in mechanically-induced 
endogenous tissue engineering and de novo bone formation within the 
distracted gap. While graft-free, a main limitation of the procedure 
remains the lengthy period of time required for the newly formed bone 
to consolidate entailing prolonged external fixation (thereby diminishing 
the high concentration of anabolic growth factors in the regenerate 
due to cortical and cancellous bone remodelling and maturation) with 
considerable morbidity.3,4 
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Treatment outcomes and quantity:quality of 
regenerate from osteodistraction (and histiogenesis: 
specialized soft tissue growth) can also be affected by 
the presence of systemic disease and use of medications. 
Hence, the drive for developing novel bone tissue 
engineering methods continues, with 3 main strategies 
undergoing vigorous investigation: the transduction of 
genes encoding cytokines with osteogenic capacity into 
cells at repair sites (gene therapy); the transplantation of 
cultured osteogenic cells derived from host bone marrow 
(cell therapy) and the application of osteoinductive 
growth factors (protein therapy). 
Gene- and stem cell-based therapy will probably 
represent the next major advance however presently are 
still in their infancy regarding safety and efficacy. Protein 
therapy, on the other hand, has demonstrated considerable 
practical promise, mainly via incorporating osteogenic 
morphogens such as bone morphogenetic proteins (BMPs) 
even so with some limitations and shortcomings. 
Briefly, BMPs are potent cytokines able to induce new 
bone formation in vitro and in vivo; and have been efficacious 
in the reconstruction of long bones, spine, as well as the 
craniofacial skeleton; pre-clinically and clinically.4,5 While 
osteodistraction is not a FDA-authorized indication and/or 
application, attempts to manipulate regenerate bone using 
commercially-available BMPs, mainly BMP-2 (InductOs®, 
Infuse®) and BMP-7/OP-1 (Osigraft®), have been used off-
label. The first and foremost caution (yet controversial) is 
that growth factors may involve a risk of inducing cancer; 
especially in children, despite conclusions from large cohort 
studies (use of BMP-2 in lumbar spondyloses in the elderly) 
not reporting such risk. In Canada, for example, growth 
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factors can be indicated during pediatric osteodistraction 
to enhance healing and augment the bone grafting 
procedures in cases of orthopaedic non-union.4-6
BMPs act locally; yet, the exact/full cellular and 
molecular mechanisms are not fully understood. Small 
amounts induce cellular responses in vitro, however, when 
administered in vivo, rapid degradation and consequently 
insufficient and improper tissue regeneration occurs. 
Further, we know today that the clinical efficacy of 
recombinant human (rh) forms of BMPs will always depend 
on the carrier system used to ensure an effective delivery 
of adequate protein concentrations to the desired site.4,6 
While several materials for rhBMPs delivery have been 
developed, only specific collagen-based formulations for 
rhBMP-2 and rhOP-1 (rhBMP-7) obtained FDA approval 
for their restricted use in humans; orthopaedic and spinal 
fusion applications4-7 
It is also clear that there can be no one single best-
fit delivery system for all growth factors, pathologies or 
indications, especially so in critical-sized defects. Likewise, 
there is probably not a single desirable pharmacokinetic 
profile that is predictive of success. Few have investigated 
the influence of release kinetics on bone regeneration, 
remodelling and repair. Maintaining a critical threshold 
concentration of exogenous cytokines at the defect site 
(or callus in cases of osteodistraction) for the necessary 
period of time (temporal distribution) is crucial. For 
example, higher retention times for BMP-2 were more 
osteoinductive when compared to short-term delivery at 
the equivalent dosage.4,8 
It is apparent today that extremes of release (bolus 
injections or prolonged low level release) and speed (slow 
Figure 1. A. Bone Tissue Engineering approaches according to complexity/difficulty of osseous defect. 
B. The Diamond ◊Concept (introducing stability to earlier Δ Triad) for osseoregeneration leading to 
a functional ‘engineered’ vascularized tissue equivalent.
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versus fast) are not necessarily or significantly beneficial to 
bone induction. Nonetheless, while timing of the protein 
release is important, the dynamic nature of the healing 
zone makes it difficult to assess the state of the defect. It 
is also noteworthy to the interested reader that different 
animal models; species, ages and sizes, may have varying 
optimum release profiles. It is important thereby to 
emphasize again that the enhancement of bone healing by 
BMPs is predominantly dependant on the parameters of a 
combined localized and release-controlled carrier/delivery 
system including the aforementioned: protein release 
kinetics and retention, BMP dose size/concentration, 
mechanism of release and nature of the vehicle used in 
terms of biomaterial(s) and design/geometry. 
Collectively, novel controlled-release carriers need to 
contain the cytokine(s), prevent ectopic/heterotopic bone 
formation and utilize safe and cost-effective dosages. 
They should have the ability to provoke optimal localized 
inflammatory responses, be biocompatible and are often 
required to be bio-resorbable. Processing conditions need 
to prevent protein aggregation or denaturation. Also, 
they have to be easily and cost-effectively manufactured 
for large-scale production. Appropriate storage, stability, 
handling and sterilization conditions are favored as 
well. All such desirable and eagirly-pursued/-awaited 
progressions need to serve and facilitate the sought-after 
approval by regulatory agencies; a far from easy, economic 
or rapid translational process.
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